Zentalis Pharmaceuticals Ratios (2019-2026) | ZNTL

1Y3Y5Y7Y10YAll
Download Data
Ratios Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
25.11%-177.47%
EBIT Margin (Quarter)
-61.06%-185.55%
EBITDA Margin (Quarter)
-61.06%-185.55%
Operating Margin (Quarter)
-61.06%-185.55%
Net Margin (Quarter)
24.75%-176.71%
FCF Margin (Quarter)
-128.24%-147.78%
Efficiency
Assets Average (Quarter)
306.16M359.52M444.79M430.09M486.77M548.52M534.25M514.33M555.39M603.58M568.70M554.58M524.58M471.17M440.50M407.18M367.86M339.48M308.11M271.02M
Asset Utilization Ratio (Quarter)
0.070.080.090.150.070.070.08
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-47.08-69.24-8.51-9.33-0.73-2.63-1.48-0.92-10.61-0.37-1.02-2.76-0.20-0.78-0.63-2.27-0.00M-0.73
Times Interest Earned (Quarter)
-47.08-69.24-8.51-9.33-0.73-2.63-1.48-0.92-10.61-0.37-1.02-2.76-0.20-0.78-0.63-2.27-0.00M-0.73
Valuation
Enterprise Value (Quarter)
-25.65M-40.49M-59.43M-30.45M-54.81M-42.32M-42.85M-36.10M-266.42M-110.62M-27.93M-37.62M-36.98M-41.32M-53.08M-320.30M-54.39M-41.48M-245.89M-211.76M
Return Ratios
Return on Sales (Quarter)
0.00%-0.05%-0.04%-0.02%-0.08%-0.06%-0.06%
Return on Capital Employed (Quarter)
-66.22%-65.16%-54.02%-57.96%-53.04%-45.25%-47.59%-51.17%-54.57%-52.02%-59.98%-51.89%-48.17%-50.27%-49.31%-59.27%-55.64%-54.67%-56.27%-61.51%
Return on Assets (Quarter)
-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%